
Sign up to save your podcasts
Or


Gilead’s experimental Covid-19 treatment caught the markets’ attention after STAT News reported encouraging early results in its phase 3 trial. Former FDA Commissioner Dr. Scott Gottlieb explains the antiviral Remdesivir and explains its potential role in flattening the pandemic’s curve. French pharmaceutical company Sanofi has partnered with peer GlaxoSmithKline to develop a Covid-19 vaccine in the next 18 months. Sanofi has also partnered with a startup to create a coronavirus test using a smartphone. CEO Paul Hudson explains the news, the technology, and the path ahead for a healthier planet.
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
By CNBC4.2
525525 ratings
Gilead’s experimental Covid-19 treatment caught the markets’ attention after STAT News reported encouraging early results in its phase 3 trial. Former FDA Commissioner Dr. Scott Gottlieb explains the antiviral Remdesivir and explains its potential role in flattening the pandemic’s curve. French pharmaceutical company Sanofi has partnered with peer GlaxoSmithKline to develop a Covid-19 vaccine in the next 18 months. Sanofi has also partnered with a startup to create a coronavirus test using a smartphone. CEO Paul Hudson explains the news, the technology, and the path ahead for a healthier planet.
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

4,070 Listeners

3,219 Listeners

1,358 Listeners

240 Listeners

150 Listeners

527 Listeners

326 Listeners

68 Listeners

153 Listeners

1,044 Listeners

28 Listeners

349 Listeners

45 Listeners

2,118 Listeners

594 Listeners

5 Listeners

20 Listeners

10,041 Listeners

1,568 Listeners

404 Listeners

302 Listeners

119 Listeners

807 Listeners

158 Listeners

36 Listeners

13 Listeners

30 Listeners

10 Listeners

16 Listeners

0 Listeners